T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours

Stefanie Lesch(Center for Integrated Protein Science Munich), Viktoria Blumenberg(Center for Integrated Protein Science Munich), Stefan Stoiber(Center for Integrated Protein Science Munich), Adrian Gottschlich(Center for Integrated Protein Science Munich), Justyna Ogonek(Center for Integrated Protein Science Munich), Bruno L. Cadilha(Center for Integrated Protein Science Munich), Zahra Dantes(TUM Klinikum), Felicitas Rataj(Center for Integrated Protein Science Munich), Klara Dorman(Center for Integrated Protein Science Munich), Johannes Lutz(Center for Integrated Protein Science Munich), Clara H. Karches(Center for Integrated Protein Science Munich), Constanze Heise(Center for Integrated Protein Science Munich), Mathias Kurzay(Center for Integrated Protein Science Munich), Benjamin M. Larimer(Massachusetts General Hospital), G Simon(Center for Integrated Protein Science Munich), Moritz Rapp(Center for Integrated Protein Science Munich), Alessia Nottebrock(Center for Integrated Protein Science Munich), Stephan Krüger(Center for Integrated Protein Science Munich), Nicholas Tokarew(Center for Integrated Protein Science Munich), Philipp Metzger(Center for Integrated Protein Science Munich), Christine Hoerth(Center for Integrated Protein Science Munich), Mohamed-Reda Benmebarek(Center for Integrated Protein Science Munich), Dario Dhoqina(Center for Integrated Protein Science Munich), Ruth Grünmeier(Center for Integrated Protein Science Munich), Matthias Seifert(Center for Integrated Protein Science Munich), Arman Oener(Center for Integrated Protein Science Munich), Öykü Umut(Center for Integrated Protein Science Munich), Sandy Joaquina(Centre National de la Recherche Scientifique), Lene Vimeux(Centre National de la Recherche Scientifique), Thi Tran(Inserm), Thomas Hank(Harvard University), Taisuke Baba(Harvard University), Duc Huynh(Center for Integrated Protein Science Munich), Remco T. A. Megens(Maastricht University), Klaus‐Peter Janssen(TUM Klinikum), Martin Jastroch(Helmholtz Zentrum München), Daniel Lamp(Helmholtz Zentrum München), Svenja Ruehland(Ludwig-Maximilians-Universität München), Mauro Di Pilato(Massachusetts General Hospital), Jasper N. Pruessmann(Massachusetts General Hospital), Moritz Thomas(Helmholtz Zentrum München), Carsten Marr(Helmholtz Zentrum München), Steffen Ormanns(Ludwig-Maximilians-Universität München), Anna Reischer(Ludwig-Maximilians-Universität München), Michael Hristov(Ludwig-Maximilians-Universität München), Éric Tartour(Inserm), Emmanuel Donnadieu(Centre National de la Recherche Scientifique), Simon Rothenfußer(Center for Integrated Protein Science Munich), Peter Duewell(University of Bonn), Lars M. König(Center for Integrated Protein Science Munich), Max Schnurr(Center for Integrated Protein Science Munich), Marion Subklewe(Ludwig-Maximilians-Universität München), Andrew S. Liss(Harvard University), Niels Halama(German Cancer Research Center), Maximilian Reichert(German Cancer Research Center), Thorsten R. Mempel(Massachusetts General Hospital), Stefan Endres(German Cancer Research Center), Sebastian Kobold(German Cancer Research Center)
Nature Biomedical Engineering
June 3, 2021
Cited by 172Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis